Skip Nav Destination
Issues
15 March 2020
-
Cover Image
Cover Image
The image shows immunohistochemical staining of a human colonic polyp biopsy, demonstrating intestinal epithelial cells highlighted by nuclear staining (brown) surrounded by smooth-muscle cells (red) and fibroblasts (purple). The distinction among different types of colonic polyps often presents a significant diagnostic challenge with high interobserver variability. We identified an extracellular matrix protein, agrin, as a novel biomarker identifying high-risk colonic polyps by its localization in the muscularis mucosa underlying the colonic epithelium. For details, see article by Rickelt and colleagues on page 1277 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
Clinical Trials: Targeted Therapy
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Kristina A. Cole; Sharmistha Pal; Rachel A. Kudgus; Heba Ijaz; Xiaowei Liu; Charles G. Minard; Bruce R. Pawel; John M. Maris; Daphne A. Haas-Kogan; Stephan D. Voss; Stacey L. Berg; Joel M. Reid; Elizabeth Fox; Brenda J. Weigel
Author Choice
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S. Hong; Nicole Concin; Ignace Vergote; Johann S. de Bono; Brian M. Slomovitz; Yvette Drew; Hendrik-Tobias Arkenau; Jean-Pascal Machiels; James F. Spicer; Robert Jones; Martin D. Forster; Nathalie Cornez; Christine Gennigens; Melissa L. Johnson; Fiona C. Thistlethwaite; Reshma A. Rangwala; Srinivas Ghatta; Kristian Windfeld; Jeffrey R. Harris; Ulrik Niels Lassen; Robert L. Coleman
A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors
Andrea Varga; Jean-Charles Soria; Antoine Hollebecque; Patricia LoRusso; Johanna Bendell; Shih-Min A. Huang; Marie-Claire Wagle; Kwame Okrah; Lichuan Liu; Elaine Murray; Sandra M. Sanabria-Bohorquez; Michael Tagen; Hatem Dokainish; Lars Mueller; Howard Burris
Author Choice
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors
Gerald S. Falchook; Razelle Kurzrock; Hesham M. Amin; Wenyuan Xiong; Siqing Fu; Sarina A. Piha-Paul; Filip Janku; Ghazaleh Eskandari; Daniel V. Catenacci; Manfred Klevesath; Rolf Bruns; Uz Stammberger; Andreas Johne; Friedhelm Bladt; Manja Friese-Hamim; Pascal Girard; Samer El Bawab; David S. Hong
Author Choice
Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies
Gerald Falchook; Seth Rosen; Patricia LoRusso; Justin Watts; Shilpa Gupta; Catherine C. Coombs; Moshe Talpaz; Razelle Kurzrock; Monica Mita; Ryan Cassaday; Wael Harb; Julio Peguero; David C. Smith; Sarina A. Piha-Paul; Russ Szmulewitz; Marcus S. Noel; Swamy Yeleswaram; Phillip Liu; Julie Switzky; Gongfu Zhou; Fred Zheng; Amitkumar Mehta
Clinical Trials: Immunotherapy
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Emily Z. Keung; Melissa Burgess; Ruth Salazar; Edwin R. Parra; Jaime Rodrigues-Canales; Vanessa Bolejack; Brian A. Van Tine; Scott M. Schuetze; Steven Attia; Richard F. Riedel; James Hu; Scott H. Okuno; Dennis A. Priebat; Sujana Movva; Lara E. Davis; Damon R. Reed; Alexandre Reuben; Christina L. Roland; Denise Reinke; Alexander J. Lazar; Wei-Lien Wang; Jennifer A. Wargo; Hussein A. Tawbi
Precision Medicine and Imaging
Author Choice
Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
Parisa Malekzadeh; Rami Yossef; Gal Cafri; Biman C. Paria; Frank J. Lowery; Mohammad Jafferji; Meghan L. Good; Abraham Sachs; Amy R. Copeland; Sanghyun P. Kim; Scott Kivitz; Maria R. Parkhurst; Paul F. Robbins; Satyajit Ray; Liqiang Xi; Mark Raffeld; Zhiya Yu; Nicholas P. Restifo; Robert P.T. Somerville; Steven A. Rosenberg; Drew C. Deniger
Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions
Steffen Rickelt; Charlene Condon; Miyeko Mana; Charlie Whittaker; Christina Pfirschke; Jatin Roper; Deepa T. Patil; Ian Brown; Anthony R. Mattia; Lawrence Zukerberg; Qing Zhao; Runjan Chetty; Gregory Y. Lauwers; Azfar Neyaz; Lieve G.J. Leijssen; Katherine Boylan; Omer H. Yilmaz; Vikram Deshpande; Richard O. Hynes
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218
Angeles Alvarez Secord; Kirsten Bell Burdett; Kouros Owzar; David Tritchler; Alexander B. Sibley; Yingmiao Liu; Mark D. Starr; J. Chris Brady; Heather A. Lankes; Herbert I. Hurwitz; Robert S. Mannel; Krishnansu S. Tewari; David M. O'Malley; Heidi Gray; Jamie N. Bakkum-Gamez; Keiichi Fujiwara; Matthew Boente; Wei Deng; Robert A. Burger; Michael J. Birrer; Andrew B. Nixon
Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response
Thomas Payen; Paul E. Oberstein; Niloufar Saharkhiz; Carmine F. Palermo; Stephen A. Sastra; Yang Han; Alireza Nabavizadeh; Irina R. Sagalovskiy; Barbara Orelli; Vilma Rosario; Deborah Desrouilleres; Helen Remotti; Michael D. Kluger; Beth A. Schrope; John A. Chabot; Alina C. Iuga; Elisa E. Konofagou; Kenneth P. Olive
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma
Mark A. Applebaum; Erin K. Barr; Jason Karpus; Diana C. West-Szymanski; Meritxell Oliva; Elizabeth A. Sokol; Sheng Zhang; Zhou Zhang; Wei Zhang; Alexandre Chlenski; Helen R. Salwen; Emma Wilkinson; Marija Dobratic; Robert L. Grossman; Lucy A. Godley; Barbara E. Stranger; Chuan He; Susan L. Cohn
Translational Cancer Mechanisms and Therapy
Author Choice
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Jiajia Zhang; Zhicheng Ji; Justina X. Caushi; Margueritta El Asmar; Valsamo Anagnostou; Tricia R. Cottrell; Hok Yee Chan; Prerna Suri; Haidan Guo; Taha Merghoub; Jamie E. Chaft; Joshua E. Reuss; Ada J. Tam; Richard L. Blosser; Mohsen Abu-Akeel; John-William Sidhom; Ni Zhao; Jinny S. Ha; David R. Jones; Kristen A. Marrone; Jarushka Naidoo; Edward Gabrielson; Janis M. Taube; Victor E. Velculescu; Julie R. Brahmer; Franck Housseau; Matthew D. Hellmann; Patrick M. Forde; Drew M. Pardoll; Hongkai Ji; Kellie N. Smith
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
Asfar S. Azmi; Husain Yar Khan; Irfana Muqbil; Amro Aboukameel; Jasper E. Neggers; Dirk Daelemans; Amit Mahipal; Gregory Dyson; Mandana Kamgar; Mohammad Najeeb Al-Hallak; Anteneh Tesfaye; Steve Kim; Vinod Shidham; Ramzi M. Mohammad; Philip A. Philip
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Sabrina Arena; Giorgio Corti; Erika Durinikova; Monica Montone; Nicole M. Reilly; Mariangela Russo; Annalisa Lorenzato; Pamela Arcella; Luca Lazzari; Giuseppe Rospo; Massimiliano Pagani; Carlotta Cancelliere; Carola Negrino; Claudio Isella; Alice Bartolini; Andrea Cassingena; Alessio Amatu; Gianluca Mauri; Andrea Sartore-Bianchi; Gloria Mittica; Enzo Medico; Silvia Marsoni; Michael Linnebacher; Sergio Abrignani; Salvatore Siena; Federica Di Nicolantonio; Alberto Bardelli
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer
Jennifer B. Goldstein; Li Zhao; Xuemei Wang; Yael Ghelman; Michael J. Overman; Milind M. Javle; Rachna T. Shroff; Gauri R. Varadhachary; Robert A. Wolff; Florencia McAllister; Andrew Futreal; David R. Fogelman
EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma
Shaofang Wu; Feng Gao; Siyuan Zheng; Chen Zhang; Emmanuel Martinez-Ledesma; Ravesanker Ezhilarasan; Jie Ding; Xiaolong Li; Ningping Feng; Asha Multani; Erik P. Sulman; Roel G. Verhaak; John F. de Groot; Tim P. Heffernan; W.K. Alfred Yung; Dimpy Koul
Author Choice
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models
John O. DaSilva; Katie Yang; Andres E. Perez Bay; Julian Andreev; Peter Ngoi; Erica Pyles; Matthew C. Franklin; Drew Dudgeon; Ashique Rafique; Anthony Dore; Frank J. Delfino; Terra B. Potocky; Robert Babb; Gang Chen; Douglas MacDonald; William C. Olson; Gavin Thurston; Christopher Daly
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Sarah Greene; Yvette Robbins; Wojciech K. Mydlarz; Angel P. Huynh; Nicole C. Schmitt; Jay Friedman; Lucas A. Horn; Claudia Palena; Jeffrey Schlom; Dean Y. Maeda; John A. Zebala; Paul E. Clavijo; Clint Allen
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Patricia Fernández-Nogueira; Mario Mancino; Gemma Fuster; Anna López-Plana; Patricia Jauregui; Vanesa Almendro; Estel Enreig; Silvia Menéndez; Federico Rojo; Aleix Noguera-Castells; Anke Bill; L. Alex Gaither; Laia Serrano; Leire Recalde-Percaz; Núria Moragas; Raul Alonso; Elisabet Ametller; Ana Rovira; Ana Lluch; Joan Albanell; Pere Gascon; Paloma Bragado
Author Choice
Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis
Sijia Liu; Román González-Prieto; Mengdi Zhang; Paul P. Geurink; Raymond Kooij; Prasanna Vasudevan Iyengar; Maarten van Dinther; Erik Bos; Xiaobing Zhang; Sylvia E. Le Dévédec; Bob van de Water; Roman I. Koning; Hong-Jian Zhu; Wilma E. Mesker; Alfred C.O. Vertegaal; Huib Ovaa; Long Zhang; John W.M. Martens; Peter ten Dijke
Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
Janis V. de la Iglesia; Robbert J.C. Slebos; Laura Martin-Gomez; Xuefeng Wang; Jamie K. Teer; Aik Choon Tan; Travis A. Gerke; Garrick Aden-Buie; Tessa van Veen; Jude Masannat; Ritu Chaudhary; Feifei Song; Michelle Fournier; Erin M. Siegel; Matthew B. Schabath; J. Trad Wadsworth; Jimmy Caudell; Louis Harrison; Bruce M. Wenig; Jose Conejo-Garcia; Juan C. Hernandez-Prera; Christine H. Chung
Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression
Guang Chen; Xiao-Fei Ding; Kyle Pressley; Hakim Bouamar; Bingzhi Wang; Guixi Zheng; Larry E. Broome; Alia Nazarullah; Andrew J. Brenner; Virginia Kaklamani; Ismail Jatoi; Lu-Zhe Sun
FLASH Irradiation Spares Lung Progenitor Cells and Limits the Incidence of Radio-induced Senescence
Charles Fouillade; Sandra Curras-Alonso; Lorena Giuranno; Eddy Quelennec; Sophie Heinrich; Sarah Bonnet-Boissinot; Arnaud Beddok; Sophie Leboucher; Hamza Umut Karakurt; Mylène Bohec; Sylvain Baulande; Marc Vooijs; Pierre Verrelle; Marie Dutreix; Arturo Londoño-Vallejo; Vincent Favaudon
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome
Christian Brieghel; Caspar da Cunha-Bang; Christina Westmose Yde; Ane Yde Schmidt; Savvas Kinalis; Ferran Nadeu; Michael Asger Andersen; Line Offenbach Jacobsen; Mette Klarskov Andersen; Lone Bredo Pedersen; Julio Delgado; Tycho Baumann; Mattias Mattsson; Larry Mansouri; Richard Rosenquist; Elias Campo; Finn Cilius Nielsen; Carsten Utoft Niemann
Author Choice
Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer
Qi Cao; Zhengshuai Song; Hailong Ruan; Cheng Wang; Xiong Yang; Lin Bao; Keshan Wang; Gong Cheng; TianBo Xu; Wen Xiao; Zhiyong Xiong; Di Liu; Ming Yang; Diwei Zhou; Hongmei Yang; Ke Chen; Xiaoping Zhang
Expression of Concern
Expression of Concern: HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
Andrea Napolitano; Daniel J. Antoine; Laura Pellegrini; Francine Baumann; Ian Pagano; Sandra Pastorino; Chandra M. Goparaju; Kirill Prokrym; Claudia Canino; Harvey I. Pass; Michele Carbone; Haining Yang
Editor’s Notes
Editor's Note: Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-mediated Potentiation of Bortezomib-induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells
Rekha Rao; Srilatha Nalluri; Warren Fiskus; Andrew Savoie; Kathleen M. Buckley; Kyungsoo Ha; Ramesh Balusu; Atul Joshi; Veena Coothankandaswamy; Jianguo Tao; Eduardo Sotomayor; Peter Atadja; Kapil N. Bhalla
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.